- Research
- Open access
- Published:
Spectrum and prevalence of renal dysfunction among heart failure patients attending tertiary care hospital: first report from Somalia
The Egyptian Journal of Internal Medicine volume 35, Article number: 70 (2023)
Abstract
Introduction
Heart failure is one of the major global health problems that we face today, worldwide. The main objective of our study is to evaluate the spectrum and prevalence of renal dysfunction among heart failure patients in Mogadishu, Somalia. The design of the study is a retrospective descriptive study aimed at heart failure patients who presented to the largest tertiary care center in southern somalia between January 2021 to september 2021. Demographic data, co-morbidities, types of heart failure, causes of heart failure and the presence or absence of renal dysfunction were analysed.
Results
Overall 180 heart failure patients were enrolled in the study. The mean age of the participants was 62.26 ± 14 years. Regarding the age group, patients aged between 61–80 years was the most abundant participants with (n = 87, 48.3%). Regarding the type of heart failure in our study, HFpEF was the most common type in our respondents with frequency of (n = 85, 47.2%). When analysed the cause of heart failure among patients; hypertension was the most common cause of heart failure (n = 90, 50%). Also, hypertension was the most common co-morbidity among our patients (n = 106, 59%), followed by coronary artery diseases (n = 50, 28%). The prevalence of renal dysfunction in heart failure patients was (n = 37, 20.6%). Our analysis showed that among the 37 renal dysfunction patients, 12.3% of them (n = 22) were CKD (chronic kidney disease) while the remaining 8.3% (n = 15) had AKI (acute kidney injury). We found a significant correlation between gender and renal dysfunction in heart failure patients with (95% CI: 0.098–0.574, OR: 0.237, p value: < 0.001). Males were 2 and half times more likely to develop renal failure than females.
Conclusions
we found that the prevalence of renal dysfunction in heart failure patients is 20.6%. It was more prevalent in males and elderly population.
Introduction
Heart failure is one of the major global health problems that we face today, worldwide. It is estimated that 38 million people in the world are living with heart failure, and some studies have concluded that heart failure has a poorer prognosis than some cancers [1]. At the moment, 2% to 4% of the world’s population has chronic heart failure. The 5-year death rate for women due to heart failure is 45%, while the 5-year death rate for men is 60% [2].
It is known that patients who have congestive heart failure have the greatest risk of developing acute renal dysfunction [3]. CKD is also a common finding in heart failure patients, approximately 50% of heart failure patients, because they have many similar risk factors that can lead to both of the diseases [4]. CKD and heart failure often coincide at the same time, and having both at the same time is far worse than having either one alone [5].
Additionally, CKD alone can contribute to poor outcomes in patients suffering from heart failure [6]. Furthermore, heart failure can also be seen in patients who are already suffering from CKD and is also a leading complication of death in these patients [7]. Furthermore, heart failure is a strong and independent predictor of mortality among hemodialysis and peritoneal dialysis patients [8, 9]. Although some studies have described the prevalence of renal dysfunction in heart failure patients in the world [10, 11], it has not been deservedly studied in Somalia. There is a dearth of data regarding the prevalence, risk factors, and outcomes of renal dysfunction among heart failure patients. The main objective of our study is to evaluate the spectrum and prevalence of renal dysfunction among heart failure patients in Mogadishu, Somalia.
Methods
The design of the study is a retrospective descriptive study aimed at heart failure patients who presented to the largest tertiary care center in southern somalia [12], Mogadishu Somali Turkish Training and Research Hospital between January 2021 to september 2021. The ethical approval was granted by the ethical review institution board of the Somali Turkish Training and Research Hospital (Approval no:MSTH/7129). In addition, all patients previously consented to the use of their data for study purposes were examined. This study was carried out following the Helsinki Declarations and the personal data of the patients were not revealed.
We obtained the patients data from Mogadishu Somali Turkish Training and Research Hospital database using dates and ICD-10 diagnostic codes for both renal dysfunction and heart failure. 180 heart failure patients who came to the hospital during the study period were included in this study. Patients who were younger than 18 years, patients who had missed data from the system, and patients who did not previously consented the use of their data were excluded from this study. The patients were classified into five groups according to their age; 18–25, 26–40, 41–60, 61–80, > 80 years old, respectively.
The sociodemographic data of the patients including age and gender were analyzed during this study. Furthermore, the cause of heart failure, the type of heart failure according to ejection fraction (EF) and the presence or absence of renal impairment among these patients were also examined. Regarding the co-morbidities, we assessed the presence of diabetes mellitus, hypertension, cerebrovascular disease, hyperlipidemia, obesity, smoking and chronic obstructive pulmonary disease.
Glomerular filtration rate (GFR) was measured using The CKD Epidemiology Collaboration (CKD-EPI) formula [13]. The renal dysfunction were classified according GFR; patients who had GFR less than 60ml/min per 1.73 square meters and or presence of elevated serum creatinine for more than 3 months were considered as CKD in our study [14]. Patients who did not meet the above mentioned criteria but had an upnormal renal function were considered as AKI.
The diagnosis of heart failure was obtained with Transthoracic Echocardiographic examination. The echocardiography was performed by an experienced cardiologist using Toshiba Aplio 500 (3-5MHz probe). The echocadiographic examinations was performed from subcostal, apical and parasternal views following the recommendations of American Society of Echocardiography [15]. Heart failure with EF of less than 40% was considered as heart failure with reduced ejection fraction (HFrEF), heart failure with EF in between 40 to 50% was considered heart failure with mid-range ejection fraction, and heart failure with EF of more than 50% was considered to be heart failure with preserved ejection fraction [16].
The data was collected using Microsoft excel and was then imported to and analyzed using Statistical Package for Social Sciences (SPSS, V26, IBM, Armonk, NY, USA). The descriptive data analysis were presented as means, standard deviations and medians. We compared categorical variables using Chi-square and fisher’s test. A bivariate analysis was used to determine the association between variables. P value of less than 0.05 was considered as statistically significant result.
Results
Of the 180 heart failure patients that were enrolled in the study, the mean age of the participants was 62.26 ± 14 years. The maximum age of our respondents was 92 years while the minimum age of our respondents was 20 years. Regarding the age group, patients aged between 61–80 years was the most abundant participants (n = 87, 48.3%). The other common age groups in our study were 41–60 years old with (n = 66, 36.7%), > 80 years, 26–40 years, 18–25 years with a frequencies of (n = 13, 7.2%), (n = 12, 6.7%), and (n = 2, 1.1%), respectively. Of the 180 participants, 56.7% of them (n = 102) were males while 43.3% (n = 78) were females (Table 1).
Regarding the type of heart failure in our study, HFpEF was the most common type in our respondents with frequency of (n = 85, 47.2%), followed by HFrEF and HFmrEF with frequency of (n = 63, 35%) and (n = 32, 17.8%), respectively. Regarding the age groups; HFpEF and HFmrEF were more common in 61–80 years old patients with (51%) and (56%), while HFrEF was mostly found in 41–60 years old patients with (43%) (Table 1).
In this study, we found that the prevalence of renal dysfunction in heart failure patients to be 20.6% (n = 37). The remaining of our respondents (n = 143, 79.4%) had normal renal function. Our analysis showed that among the 37 respondents that were having renal dysfunction, 12.3% of them (n = 22) were CKD while the remaining 8.3% (n = 15) had AKI. Out of the 37 heart failure patients with renal dysfunction, (n = 30, 81%) of them were males while the remaining (n = 7, 19%) were females. AKI and CKD were both observed to be more common in males, patients with HFrEF, and patients with co-morbidities, with (93% vs 73%), (47% vs 55%), (80% vs 95%), respectively. We found a significant correlation between gender and renal dysfunction in heart failure patients with (95% CI: 0.098–0.574, OR: 0.237, p value: < 0.001). Males with heart failure were 2 and half times more likely to develop renal failure than females (Table 2).
The co-morbidities of the patients were assessed; the most common co-morbidity was hypertension (n = 106, 59%), followed by coronary artery diseases (n = 50, 28%), diabetes mellitus (n = 45, 25%), and hyperlipidemia (n = 42, 23.3%). The least common of co-morbidity in our patients was COPD (n = 14, 8.8%). Patients who are obese, those with a history of smoking, hypertension, coronary artery disease, and obesity were found to be more common to have chronic renal failure with (100%), (67%), (57%), (54%), respectively (Table 3). When analyzed the causes of heart failure among patients; hypertension was the most common cause of heart failure (n = 90, 50%), while ischemic heart disease, valvular heart disease and cardiomyopathy were (n = 52, 28.9%), (n = 31, 17.2%), (n = 7, 3.9%), respectively (Fig. 1). Hypertension was also the most common cause of heart failure in all age groups except 41–60 years old patients. The most common cause of heart failure among these patients was ischemic heart disease.
Discussion
In the general population, the prevalence of chronic kidney disease in 2014 was estimated at around 4.5% [17], but a more recent study in 2019 stated that the prevalence of chronic kidney disease was 13.4% globally [18]. Renal hypoperfusion and venous congestion are thought to be the main causes of deterioration in renal function among patients with decompensated heart failure [19, 20]. In patients with congestive heart failure with or without depressed systolic function, the presence of renal disease is found to be common and also a strong predictor of the morbidity and mortality of these patients [21]. According to Hillege and co-workers, the death rate in heart failure patients may be more heavily tied to a drop in GFR than in left ventricular ejection fraction [22]. Despite its significance and the growing number of heart failure patients, this subject is not well studied worldwide. This is the first study to report the prevalence of renal dysfunction in heart failure patients in Somalia.
In the presenting study, we found that the prevalence of renal dysfunction in heart failure patients is (20.6%). A higher prevalence rate was reported in a meta-analysis study, which evaluated over 1 million people in 2014, by Damman and colleagues. They stated that the prevalence of renal dysfunction among heart failure patients was (32%) [17]. In 2012, a study by Cleland and his colleagues stated that epidemiological studies showed that 17–30% of people with acute heart failure had renal dysfunction, and almost 60% of people with chronic heart failure had renal dysfunction [23].
Our study also found that older people with heart failure are more likely to have renal dysfunction when compared to younger people. This result is similar to the conclusion of a meta-analysis done by Damman et al. in 2014, which found that renal disease is common among the elder population with heart failure [17]. There is also a meta-analysis by Smith et al. which found that renal disease is more common in older populations with heart failure [24].
Regarding the gender of the participants, we found that renal dysfunction among heart failure patients was more common in male patients (81%) when compared to female patients (19%), with a ratio of 4:1. We also found a strong correlation between gender and renal dysfunction in heart failure patients. Males with heart failure were two times more likely to develop renal dysfunction than females.
Regarding the co-morbidities, we found that hypertension was the most prevalent co-morbidity among heart failure patients in our study. Heart failure patients who are obese and those with a history of smoking, hypertension, coronary artery disease, and obesity were found to be more likely to have chronic renal dysfunction.
In general, there are a small number of studies dealing with the prevalence and burden of renal dysfunction among heart failure patients worldwide. For example, a study by Ezekowitz et al. stated that kidney failure was more common in chronic heart failure and ischemic heart disease and also associated with coronary atherosclerosis [25]. Furthermore, Damman et al. in 2015 concluded that renal failure can occur in all types of heart failure and is associated with increased morbidity and mortality [20].
There are several limitations that should be considered before evaluating this study; first, it is a retrospective study and only focused on the patients from one single center. Second, the sample size is small and the time frame of the study is relatively short. On the other hand, as strength, Since a number of studies have shown that renal impairment can have a negative impact on the prognosis of heart failure patients worldwide, this subject has not been adequately studied in East Africa, and data on the subject is scarce in the literature. We hope that the presenting study will constitute integral part about the prevalence of renal dysfuntion among heart failure patients in east africa and could pave the way for future studies to decrease the burden of renal dysfunction among heart failure patients and to improve the quality of life among heart failure patients.
Conclusions
The prevalence of renal dysfunction in heart failure patients in the presenting study is 20.6%. Renal dysfunction with heart failure is more prevalent in males and the elderly population. There is a need for a multicentered study to evaluate the prevalence and patterns of renal dysfunction among heart failure patients in Somalia. Since renal dysfunction can contribute to poor outcomes in heart failure patients [4], early screening of the renal profile and patient education can reduce the number of heart failure patients who may develop renal dysfunction and improve the quality of life for these patients.
Availability of data and materials
The data is available from the corresponding author.
Abbreviations
- AKI:
-
Acute Kidney Injury
- CAD:
-
Coronary Artery Disease
- CKD:
-
Chronic Kidney Disease
- EF:
-
Ejection Fraction
- GFR:
-
Glomerular Filtration Rate
- HfmEF:
-
Heart Failure with Mid-Range Ejection Fraction
- HfpEF:
-
Heart Failure with Preserved Ejection Fraction
- HfrEF:
-
Heart Failure with Reduced Ejection Fraction
- ICD-10:
-
International Classification of Diseases 10
- SPSS:
-
Statistical Package for Social Sciences
References
Braunwald E (2015) The war against heart failure: the Lancet lecture. Lancet 385(9970):812–824
Bekmurodovna TK, Erkinovna EN, Gadaevich GA, Oripovna DN, Abdujalolovna KF (2020) Comorbid states in patients with chronic heart failure. Regional level of the problem (preliminary study). J Cardiovasc Dis Res 11(2):59–65
Chittineni H, Miyawaki N, Gulipelli S, Fishbane S (2007) Risk for acute renal failure in patients hospitalized for decompensated congestive heart failure. Am J Nephrol 27(1):55–62
Ahmed A, Campbell RC (2008) Epidemiology of chronic kidney disease in heart failure. Heart Fail Clin 4(4):387–399
Bansal N, Katz R, Robinson-Cohen C, Odden MC, Dalrymple L, Shlipak MG, Sarnak MJ, Siscovick DS, Zelnick L, Psaty BM, Kestenbaum B (2017) Absolute rates of heart failure, coronary heart disease, and stroke in chronic kidney disease: an analysis of 3 community-based cohort studies. JAMA Cardiol 2(3):314–318
Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J, ADHERE Scientific Advisory Committee and Investigators (2007) High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 13(6):422–30
Bagshaw SM, Cruz DN, Aspromonte N, Daliento L, Ronco F, Sheinfeld G, Anker SD, Anand I, Bellomo R, Berl T, Bobek I (2010) Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant 25(5):1406–1416
Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS (1995) Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int 47(3):884–890
Wang AY, Wang M, Lam CW, Chan IH, Lui SF, Sanderson JE (2011) Heart failure in long-term peritoneal dialysis patients: a 4-year prospective analysis. Clin J Am Soc Nephrol 6(4):805–812
Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Grady D, Shlipak MG (2004) Renal insufficiency as an independent predictor of mortality among women with heart failure. J Am Coll Cardiol 44(8):1593–1600
McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW (2004) Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 109(8):1004–1009
Jeele MO, Addow RO, Adan FN, Jimale LH (2021) Prevalence and risk factors associated with hepatitis B and hepatitis C ınfections among patients undergoing hemodialysis: a single-centre study in Somalia. Int J Nephrol 2021:1555775
Levey AS, Stevens LA (2010) Estimating GFR using the CKD epidemiology collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 55(4):622–627
Vaidya SR, Aeddula NR (2021) Chronic renal failure. In: StatPearls. StatPearls Publishing
Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH (2020) Recommendations for noninvasive evaluation of native valvular regurgitation A report from the american society of echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Indian Acad Echocardiogr Cardiovasc Imaging 4(1):58
Hajouli S, Ludhwani D (2021) Heart failure and ejection fraction. In: StatPearls. StatPearls Publishing, Treasure Island. [Updated 2021 Aug 11]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK553115/
Damman K, Valente MA, Voors AA, O’Connor CM, van Veldhuisen DJ, Hillege HL (2014) Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J 35(7):455–469
Lv JC, Zhang LX (2019) Prevalence and disease burden of chronic kidney disease. In: Renal fibrosis: mechanisms and therapies. pp 3–15
Chahal RS, Chukwu CA, Kalra PR, Kalra PA (2020) Heart failure and acute renal dysfunction in the cardiorenal syndrome. Clin Med 20(2):146
Damman K, Testani JM (2015) The kidney in heart failure: an update. Eur Heart J 36(23):1437–1444
Shamagian LG, Román AV, Pérez MP, Otero IG, Lamela AV, González-Juanatey JR (2006) Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile. Rev Esp Cardiol (Engl Ed) 59(2):99–108
Hillege HL, Girbes AR, De Kam PJ, Boomsma F, De Zeeuw D, Charlesworth A, Hampton JR, Van Veldhuisen DJ (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102(2):203–210
Cleland JG, Carubelli V, Castiello T, Yassin A, Pellicori P, Antony R (2012) Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Fail Rev 17(2):133–149
Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM (2006) Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47(10):1987–1996
Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML, APPROACH Investigators (2004) The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 44(8):1587–92
Acknowledgements
Not applicable.
Funding
The authors declare that they have no funding source for this study.
Author information
Authors and Affiliations
Contributions
MOOJ brought the concept of the study, performed data collection, performed data analysis, and drafted the manuscript. AAH participated the data collection and drafting of the manuscript. MAM participated the data collection and data analysis. AAA participated the data collection and data analysis. MFYM participated data analysis and revised the manuscript for important intellectual content.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The ethical approval was granted by the ethical review institution board of the Somali Turkish Training and Research Hospital (Approval no:MSTH/7129).
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jeele, M.O.O., Hussein, A.A., Mohamud, M.A. et al. Spectrum and prevalence of renal dysfunction among heart failure patients attending tertiary care hospital: first report from Somalia. Egypt J Intern Med 35, 70 (2023). https://doi.org/10.1186/s43162-023-00253-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s43162-023-00253-w